ClinicalTrials.Veeva

Menu

Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria (EBLSE)

U

University Hospital, Strasbourg, France

Status

Enrolling

Conditions

Urinary Tract Infections

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increasingly complex. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) pose a particular challenge due to their increased resistance to many commonly used antibiotics. The aim of this thesis is to study the management of such infections by general practitioners in Bas-Rhin and to suggest possible avenues for improvement.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult (≥18 years old)
  • Subject with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024
  • Subject not objecting, after being informed, to the reuse of their data for the purposes of this research.
  • The subject's primary care physician agreeing to participate in the study

Exclusion criteria

  • Subject and/or their primary care physician having expressed their opposition to participating in the study
  • Subject under legal protection
  • Subject under guardianship or curatorship

Trial contacts and locations

1

Loading...

Central trial contact

Yves HANSMANN, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems